Apixaban Market
The Apixaban market is also likely to grow as a result of significant investments being made by both public and private institutions in healthcare research and development. Apixaban's negative side effects, such as an increased risk of thrombotic events after premature discontinuation and bleeding, are anticipated to prevent widespread use. This is then anticipated to have a negative impact on market expansion. The risk of bleeding associated with using apixaban was discussed in a 2017 study that was published in Current Medical Research and Opinion.
Read More:
https://knackersblogger.blogspot.com/2023/02/apixaban-market-size-share-outlook-and.html
